52
MEMBROFENIN SCINTIGRAPHY IN BILE DISORDERS Presenter: Dr. Ravishwar Narayan

Mebrofenin scintigraphy in bile disorders

Embed Size (px)

Citation preview

Page 1: Mebrofenin scintigraphy in bile disorders

MEMBROFENIN SCINTIGRAPHY IN BILE

DISORDERS

Presenter: Dr. Ravishwar Narayan

Page 2: Mebrofenin scintigraphy in bile disorders

INTRODUCTION

Page 3: Mebrofenin scintigraphy in bile disorders

Hepatobiliary scintigraphy evaluates hepatocellular function and the biliary system by tracing the production and flow of bile from the formative phase in the liver, and its passage through the biliary system into the small intestine.

Page 4: Mebrofenin scintigraphy in bile disorders

INDICATIONS

Page 5: Mebrofenin scintigraphy in bile disorders

Neonatal hyperbilirubinemia (biliary atresia vs. neonatal hepatitis)

Enterogastric (duodenogastric) reflux assessment

Assessment of biliary enteric bypass for bile leakage (e.g., Kasai procedure)

Esophageal bile reflux after gastrectomyAcute cholecystitisChronic cholecystitis

Page 6: Mebrofenin scintigraphy in bile disorders

RADIOPHARMACY

Page 7: Mebrofenin scintigraphy in bile disorders

Radionuclide

99mTc t1/2: 6 hours

Energies: 140 keV

Radiopharmaceutical

◦IDA (Imino Diacetic Acid)◦DISIDA (2,6-diisopropylacetanilido-iminodiacetic

acid)◦BRIDA (2,4,6-trimethyl,5-bromoacetanilido-

iminodiacetic acid/ mebrofenin)

Page 8: Mebrofenin scintigraphy in bile disorders

Biokinetic features of Tc-99m mebrofenin and Tc-99m disofenin

Page 9: Mebrofenin scintigraphy in bile disorders

Albumin delivers the radiotracer to the space of Disse. Tc-99m HIDA is taken up by the hepatocyte and secreted into bile canaliculi in free form where it mixes with the hepatic bile and serves as an ideal in vivo tracer for imaging of the entire hepatobiliary tree

Page 10: Mebrofenin scintigraphy in bile disorders

PATIENT PREPARATION

NPO for 4–6 hours (2 hours for infants)

no opiates for 4 to 8 hours prior to exam

Explain the procedure

Page 11: Mebrofenin scintigraphy in bile disorders

EQUIPMENT & COMPUTER SETUP

Page 12: Mebrofenin scintigraphy in bile disorders

Camera: Large field of view

Collimator: LEAP/ LEHR

Computer Set-up◦Static Images: 500,000–1 million counts◦Flow Studies: 2 sec/frame for 60 seconds, then

immediate blood pool image◦Dynamic Studies: 60 sec/frame for 60–90

minutes◦Delayed images may be needed till 24 hrs

Page 13: Mebrofenin scintigraphy in bile disorders

Positioning:

◦patient supine ◦camera anterior ◦liver in upper left quadrant of field of view

Page 14: Mebrofenin scintigraphy in bile disorders

PHARMACOLOGIC INTERVENTIONS

Page 15: Mebrofenin scintigraphy in bile disorders

Cholecystokinin:◦If patient is NPO for many hours, GB becomes

inactive, may be full of bile or sludge and so may not visualize. CCK is used to contract gallbladder so that visualization of bowel may occur after refilling

◦0.02 µg/ kg body wt. slow IV ◦Contraindication: recent positive ultrasound

examination for gallstones.

Page 16: Mebrofenin scintigraphy in bile disorders

Morphine Sulphate :

◦When acute cholecystitis is suspected and the gallbladder is not seen by 30–60 min, 0.04 mg/kg morphine sulfate may be administered slow I.V.

◦If the cystic duct is patent, flow of bile into the gallbladder will be facilitated by morphine-induced temporary spasm of the sphincter of Oddi

◦Imaging is continued for another 30–60 min after morphine administration.

Page 17: Mebrofenin scintigraphy in bile disorders

◦Imaging after morphine injection distinguishes between acute [no visualization] and chronic [eventual visualization] cholecystitis.

◦Contraindications: increased intracranial pressure in children respiratory depression in non-ventilated patients allergic to morphine history of pancreatitis

Page 18: Mebrofenin scintigraphy in bile disorders

Phenobarbital ◦5 mg/ kg/day in two equally divided doses, for

5–7 days prior to cholescintigraphy.

◦Phenobarbital stimulates bile production and increases the secretion of the radiotracer into bile, enabling better delineation of bile ducts and duodenum in infants with neonatal hepatitis, but not in those with congenital biliary atresia

Page 19: Mebrofenin scintigraphy in bile disorders

INTERPRETATION

Page 20: Mebrofenin scintigraphy in bile disorders

Normal Results

◦Visualization of liver 5–15 seconds after injection◦hepatic and common bile duct and gallbladder 5–

60 minutes.◦Intestinal activity within 10–60 minutes

◦Gallbladder filling implies a patent cystic duct and excludes acute cholecystitis with a high degree of certainty

Page 21: Mebrofenin scintigraphy in bile disorders

Normal cholescintigraphy.

Page 22: Mebrofenin scintigraphy in bile disorders

Bile leak

◦present when tracer is found in a location other than the liver, gallbladder, bile ducts, bowel, or urine

◦Causes: Post procedural: M.C.

◦cholecystectomy, liver transplant Trauma to right upper quadrant area

Page 23: Mebrofenin scintigraphy in bile disorders
Page 24: Mebrofenin scintigraphy in bile disorders
Page 25: Mebrofenin scintigraphy in bile disorders

Biliary atresia

◦Non visualization of Extra hepatic biliary tree & failure of tracer to enter the gut

◦d/d: hepatocellular disease

Page 26: Mebrofenin scintigraphy in bile disorders

Efficacy of cholescintigraphy, ultrasonography, and liver biopsy in the differential diagnosis of congenital biliary atresia from neonatal

hepatitis

Page 27: Mebrofenin scintigraphy in bile disorders

Biliary tract evaluation

Page 28: Mebrofenin scintigraphy in bile disorders

Bile reflux

◦Activity reflux from the duodenum into the stomach.

◦Spontaneously in ~8% ◦post op.

vagotomy, hemigastrectomy Bilroth II gastrojejunostomy

Page 29: Mebrofenin scintigraphy in bile disorders

1 min/frame static images showing entero-gastric reflux at 30th min

Page 30: Mebrofenin scintigraphy in bile disorders

Acute cholecystitis

◦persistent gallbladder non-visualization after 3–4 hr. of passive imaging or 30 min. after morphine administration

◦pericholecystic hepatic band of increased activity (rim sign) has been associated with severe phlegmonous or gangrenous acute cholecystitis, a surgical emergency

Page 31: Mebrofenin scintigraphy in bile disorders

RIM SIGN: pericholecystic hepatic band of increased activity

Page 32: Mebrofenin scintigraphy in bile disorders

◦Morphine-augmented hepatobiliary scintigraphy has sensitivity, specificity, positive predictive value, and negative predictive value of 95%, 99%, 97%, and 98%, respectively

(c/f USG Abd: positive predictive value of >90% in detecting acute cholecystitis)

Page 33: Mebrofenin scintigraphy in bile disorders

Chronic cholecystitis

◦gallbladder visualization within 30 min of morphine administration or on 3-4 hr delayed images

◦gallbladder that is not visualized until after the time that the bowel is visualized correlates significantly with chronic cholecystitis.

Page 34: Mebrofenin scintigraphy in bile disorders

Gallbladder EF

◦Normal: ≥ 35%

◦Abnormal: < 35% suggestive of

◦chronic cholecystitis◦cystic duct syndrome◦sphincter of Oddi spasm◦gallbladder dyskinesia

Page 35: Mebrofenin scintigraphy in bile disorders

Gallbladder EF

Page 36: Mebrofenin scintigraphy in bile disorders

◦The finding of reduced gallbladder ejection fraction in response to Cholecystokinin is a strong indicator of the need for surgical intervention

◦Negative predictive value of a normal gallbladder ejection fraction is >91%,

Page 37: Mebrofenin scintigraphy in bile disorders

False positives

(gallbladder non-visualization in the absence of acute cholecystitis)

False negatives

(gallbladder visualization in the presence of acute cholecystitis)

Insufficient fasting bile leak due to gallbladder perforation

Prolonged fasting bowel loop simulating gallbladder

Previous cholecystectomy Acute acalculous cholecystitis

Page 38: Mebrofenin scintigraphy in bile disorders

THANK YOU

Page 39: Mebrofenin scintigraphy in bile disorders
Page 40: Mebrofenin scintigraphy in bile disorders
Page 41: Mebrofenin scintigraphy in bile disorders

Causes of enterogastric reflux

Spontaneously in ~8%  post op.

◦vagotomy, ◦hemigastrectomy◦Bilroth II gastrojejunostomy

Page 42: Mebrofenin scintigraphy in bile disorders

pathophysiologymechanism of reflux is related to the lack of

normally functioning gallbladder. In the absence of the usual storage of bile

with release on cholecystokinin (CCK) stimulation, the patient develops a constant drip of bile into the duodenum.

After meals there is a postdigestive phase of food leaving the stomach, mixing with the bile pancreatic and duodenal secretions, and all being swept downstream in the normal fashion

Page 43: Mebrofenin scintigraphy in bile disorders

Two hours after a meal and especially during extended periods of fast, e.g., during sleep, the bile pools in the duodenum, most going downstream and some refluxing backward through the pylorus into the antrum.

In time, the presence of the biliary pancreatic duodenal secretions in the stomach produces such an irritant effect that significant gastritis and esophagitis result.

Page 44: Mebrofenin scintigraphy in bile disorders

criteria for the diagnosis of reflux gastritis: ◦constant burning epigastric pain◦worse after meals◦unrelieved by antacids and diet◦endoscopic demonstration of a gastric bile pool◦endoscopic biopsy proof of gastritis and

esophagitis◦hypochlorhydria.

Page 45: Mebrofenin scintigraphy in bile disorders

treatment

Medical:◦Bland diet◦Metoclopromide

Surgical:◦Roux-en-Y drainage of the biliary system and

Braun enteroenterostomy (BEE)

Page 46: Mebrofenin scintigraphy in bile disorders

Dose Range

◦Adults: 3–5 mCi higher doses (upto 15 mCi) for patients with

elevated bilirubin levels (causes less hepatic uptake, more background activity, and greater renal excretion).

◦For children: 0.05–0.07 mCi per kg minimum dose = 0.3 mCi

Page 47: Mebrofenin scintigraphy in bile disorders

Ensure patient

Ensure patient has had. Injection and imaging may be postponed 4 hours if patient has been injected with this type of medication.

Explain the procedure; usually runs ~1 hour but baseline studies can go as long as 4 hours with up to 24-hour delays required in some instances.

Page 48: Mebrofenin scintigraphy in bile disorders

indications

Page 49: Mebrofenin scintigraphy in bile disorders
Page 50: Mebrofenin scintigraphy in bile disorders

Sequential (or dynamic) images of the liver, biliary tree, and gut are obtained.

Computer acquisition and analysis, including pharmacologic interventions, are used according to varying indications and an individual patient’s needs.

Page 51: Mebrofenin scintigraphy in bile disorders

No bowel excretion or gallbladder visualization is noted small arrowhead: kidney activitylarge arrowhead:bladder

Page 52: Mebrofenin scintigraphy in bile disorders

Normal neonatal hepatobiliary scan